Article Cited by others

MOLECULES OF THE MILLENNIUM

Istaroxime: A rising star in acute heart failure

Aditya Suruchi, Rattan Aditya

Year : 2012| Volume: 3| Issue : 4 | Page no: 353-355

   This article has been cited by
 
1 Novel cinobufagin oxime ether derivatives as potential Na+/K+-ATPase inhibitors: Synthesis, biological screening and molecular docking
Guangping Liang,Tseyu Chung,Jinhua Guo,Rongrong Zhang,Wei Xü,Jason T. C. Tzen,Renwang Jiang
Chemical Research in Chinese Universities. 2017; 33(3): 378
[Pubmed]  [Google Scholar] [DOI]
2 Document Ryanodine receptor phosphorylation by oxidized CaMKII contributes to the cardiotoxic effects of cardiac glycosides
Ho, H.-T., Liu, B., Snyder, J.S.,Hund, T.J., Györke, S.
Cardiovascular Research. 2014; 101(1): 165-174
[Pubmed]  [Google Scholar]
3 Novel drug targets in clinical development for heart failure
Melvin George,Muthukumar Rajaram,Elangovan Shanmugam,Thangavel Mahalingam VijayaKumar
European Journal of Clinical Pharmacology. 2014;
[Pubmed]  [Google Scholar] [DOI]
4 Ryanodine receptor phosphorylation by oxidized CaMKII contributes to the cardiotoxic effects of cardiac glycosides
Hsiang-Ting Ho,Bin Liu,Jedidiah S. Snyder,Qing Lou,Elizabeth A. Brundage,Florencia Velez-Cortes,Honglan Wang,Mark T. Ziolo,Mark E. Anderson,Chandan K. Sen,Xander H.T. Wehrens,Vadim V. Fedorov,Brandon J. Biesiadecki,Thomas J. Hund,Sándor Györke
Cardiovascular Research. 2014; 101(1): 165
[Pubmed]  [Google Scholar] [DOI]
5 Neue medikamentöse therapieansätze bei akuter herzinsuffizienz | [Novel drug approaches in acute heart failure]
Dietz, S., Werdan, K.
Arzneimitteltherapie. 2013; 31(9): 220-232
[Pubmed]  [Google Scholar]

 

Read this article